Comparison of the efficacy of pirfenidone in patients with combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis without emphysema

被引:0
|
作者
Gwon, Hye Ran [1 ]
Kim, Song Yee [1 ,3 ]
Park, Jong Sun [2 ,3 ]
Park, Moo Suk [1 ,3 ]
机构
[1] Yonsei Univ, Severance Hosp, Div Pulmonol & Crit Care Med, Dept Internal Med,Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Div Pulmonol & Crit Care Med, Dept Internal Med, Bundang Hosp, Seoul, Gyeonggi Do, South Korea
[3] Korean ILD Study Grp, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
AP16-385
引用
收藏
页码:358 / 358
页数:1
相关论文
共 50 条
  • [31] Comparison of emphysematous COPD patients with or without Combined Pulmonary Fibrosis and Emphysema (CPFE)
    Turan, Muzaffer Onur
    Karasu, Sebnem
    Anar, Ceyda
    Sertogullarindan, Bunyamin
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [32] Combined Pulmonary Fibrosis and Emphysema
    Dodda, Venkata R.
    Salazar-Schicchi, John
    Spiro, Peter
    RESPIRATORY CARE, 2012, 57 (03) : 467 - 470
  • [33] Combined pulmonary fibrosis and emphysema
    Papiris, Spyros A.
    Triantafillidou, Christina
    Manali, Effrosyni D.
    Kolilekas, Likurgos
    Baou, Katerina
    Kagouridis, Konstantinos
    Bouros, Demosthenes
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (01) : 19 - 31
  • [34] Clinical efficacy and safety of ICS/LABA in patients with combined idiopathic pulmonary fibrosis and emphysema
    Dong, Fushi
    Zhang, Yimei
    Chi, Fangzhou
    Song, Qi
    Zhang, Lijuan
    Wang, Yupeng
    Che, Chunli
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (06): : 8617 - 8625
  • [35] Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema
    Jacob, Joseph
    Bartholmai, Brian J.
    Rajagopalan, Srinivasan
    Karwoski, Ronald
    Nair, Arjun
    Walsh, Simon L. F.
    Barnett, Joseph
    Cross, Gary
    Judge, Eoin P.
    Kokosi, Maria
    Renzoni, Elisabetta
    Maher, Toby M.
    Wells, Athol U.
    RESPIROLOGY, 2018, 23 (06) : 593 - 599
  • [36] Evaluation of vessel remodelling in patients with Combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF)
    Calabrese, F.
    Nannini, N.
    Lunardi, F.
    Balestro, E.
    Rossi, E.
    Marulli, G.
    Loy, M.
    Rea, F.
    VIRCHOWS ARCHIV, 2011, 459 : S132 - S132
  • [37] Nintedanib for the Idiopathic Pulmonary Fibrosis with Emphysema
    Krome, Susanne
    PNEUMOLOGIE, 2019, 73 (03):
  • [38] EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Inagaki, Ai
    Tsutsumi, Takeo
    Kuriyama, Sachiko
    Nagaoka, Tetsutaro
    Sekiya, Mitsuaki
    Morio, Yoshiteru
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 135 - 135
  • [39] Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone
    Sugino, Keishi
    Ishida, Fumiaki
    Kikuchi, Naoshi
    Hirota, Nao
    Sano, Go
    Sato, Keita
    Isobe, Kazutoshi
    Sakamoto, Susumu
    Takai, Yujiro
    Homma, Sakae
    RESPIROLOGY, 2014, 19 (02) : 239 - 245
  • [40] SIGNIFICANCE OF SERUM SURFACTANT PROTEIN D FOR COMBINED PULMONARY FIBROSIS WITH EMPHYSEMA IN IDIOPATHIC PULMONARY FIBROSIS
    Yokoo, Keiki
    Shiratori, Masanori
    Natsuizaka, Motoki
    Ikeda, Kimiyuki
    Otsuka, Mitsuo
    Chiba, Hirohumi
    Yamada, Gen
    Koba, Hiroyuki
    Takahashi, Hiroki
    RESPIROLOGY, 2013, 18 : 198 - 198